WallStreetZenWallStreetZen

NASDAQ: AKTS
Aktis Oncology Inc Stock Ownership - Who owns Aktis Oncology?

OverviewEarningsRevenueDividendOwnership

Insider buying vs selling

Have Aktis Oncology Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when AKTS insiders and whales buy or sell their stock.

AKTS Shareholders

What type of owners hold Aktis Oncology Inc stock?

No data
There are no institutional or insider shareholders.

AKTS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AAPG0.03%0.00%
AARD43.48%46.96%Net BuyingNet Buying
ABVX71.24%0.00%
ABUS29.82%70.18%Net Selling
ABVC3.23%86.53%
View Top Biotech Stocks

Aktis Oncology Stock Ownership FAQ

Who owns Aktis Oncology?

Aktis Oncology (NASDAQ: AKTS) is owned by 0.00% institutional shareholders, 1.75% Aktis Oncology insiders, and 98.25% retail investors.

If you're new to stock investing, here's how to buy Aktis Oncology stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.